Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperplastic proliferations of the ECL cells.

Y Dayal1

  • 1Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts.

The Yale Journal of Biology and Medicine
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.

Human pathology·2001
Same author

Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.

The American journal of gastroenterology·2000
Same author

A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: a candidate target protease, quiescent cell proline dipeptidase.

Journal of immunology (Baltimore, Md. : 1950)·1999
Same author

Recognition and the histopathologic classification of ECL cell proliferations.

The Yale journal of biology and medicine·1999
Same author

Morphology and other prognostic factors of hepatocellular carcinoma.

Archives of pathology & laboratory medicine·1999
Same author

Histological esophagitis: clinical and histological response to omeprazole in children.

Digestive diseases and sciences·1999
Same journal

Chrysoeriol-Mediated Neuroprotection in Parkinson's Disease in Mice: Targeting Apoptosis, α-Synuclein Accumulation, and Functional Recovery.

The Yale journal of biology and medicine·2026
Same journal

Musicality is Preserved in Neurodegeneration.

The Yale journal of biology and medicine·2026
Same journal

Burden of Neurological Disorders in Resource-Limited Settings: Lessons from Pakistan for Global Neurology.

The Yale journal of biology and medicine·2026
Same journal

Comparative Analysis of Prenatal Stress Models: Placental and Neurodevelopmental Outcomes in Mice.

The Yale journal of biology and medicine·2026
Same journal

Computational Investigation of Flavonoid-Associated Molecular Pathways in Astrogliosis Modulation.

The Yale journal of biology and medicine·2026
Same journal

Regulation and Interaction Among SOCS1 and SOCS3 by MicroRNAs in Multiple Sclerosis: A Review and <i>In Silico</i> Analysis.

The Yale journal of biology and medicine·2026
See all related articles

Enterochromaffin-like (ECL) cell hyperplasias can progress to carcinoids in patients with chronic hypergastrinemia. Distinguishing these from sporadic carcinoids is crucial for effective clinical management, with antrectomy showing benefit.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Oncology

Background:

  • Enterochromaffin-like (ECL) cells are the primary endocrine cells in the oxyntic mucosa.
  • These cells are sensitive to gastrin and can proliferate in hypergastrinemic states.
  • A progression from ECL cell hyperplasia to carcinoids has been observed.

Purpose of the Study:

  • To investigate the hyperplasia-neoplasia sequence of ECL cell proliferations.
  • To differentiate carcinoids arising in chronic hypergastrinemia from sporadic carcinoids.
  • To inform clinical management strategies for ECL cell carcinoids.

Main Methods:

  • Observational study of ECL cell changes in hypergastrinemic conditions.
  • Comparative analysis of clinical and pathological profiles of different carcinoid types.

Related Experiment Videos

  • Evaluation of treatment outcomes, specifically antrectomy.

    • Main Results:

    • ECL cell hyperplasias can progress to carcinoids over time.
    • Carcinoids in chronic hypergastrinemia have distinct clinical and pathological features.
    • Antrectomy demonstrated therapeutic benefit in hypergastrinemic ECL carcinoids.

    Conclusions:

    • A hyperplasia-neoplasia sequence exists for ECL cell tumors.
    • Clinical and pathological differentiation of ECL carcinoids is essential.
    • Antrectomy is a potentially beneficial treatment for ECL carcinoids in hypergastrinemic patients.